Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Samrat Pharmachem Financial Results

Samrat Pharmachem reported an annual total income of ₹290.55 Crore for FY26. The board also fixed the 34th AGM date for September 23, 2026.

Key figures
Value₹290.6 Cr
Source

BSE filing, NSE: SAMRATPH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Samrat Pharmachem Ltd: key numbers

Share price
₹266.00
Market cap
₹82.19 Cr
Revenue (annual)
₹289.7 Cr
Net profit (annual)
₹-3.31 Cr
P/E (TTM)
-37.2×Sector 46.1×
Promoter holding
49.09%+0.00% QoQ
FII holding
3.24%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Samrat Pharmachem Ltd

All →

Other financial results announcements

All →